HCAT vs TXT · rev $141.2M vs P/E 19, rev $7.52B
Health Catalyst Inc (HCAT) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Health Catalyst Inc (HCAT) is a health information services company listed on NASDAQ.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported HCAT revenue for 2026-06-30 was $141.2M. Net income was -$151.6M. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. HCAT currently screens at market cap $130.8M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
HCAT currently screens at market cap $130.8M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the HCAT and TXT stock pages for the full models.
Not investment advice.